Item 7.01 Regulation FD Disclosure.

Members of Humana Inc.'s (the "Company") senior management team are scheduled to meet with investors at various times between June 1, 2020 and June 30, 2020. During the meetings, while continuing to acknowledge the inherent uncertainty surrounding the ongoing 2019 coronavirus ("COVID-19") crisis and reiterating that it has withdrawn its additional detailed financial guidance given the likelihood of significant variability of results by financial statement line item (and related ratios), the Company intends to reaffirm its guidance range of $16.04 to $16.54 in diluted earnings per common share ("EPS"), or $18.25 to $18.75 in adjusted earnings per common share ("Adjusted EPS"), in each case for the year ending December 31, 2020 ("FY 2020"). This guidance is consistent with the guidance issued in Humana's press release dated April 29, 2020. The date and time of presentations to investors are available via the Investor Relations calendar of events on Humana's website at humana.com.

The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles ("GAAP"). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, is useful to both management and its investors in analyzing the Company's ongoing business and operating performance. Consequently, management uses Adjusted EPS as an indicator of the Company's business performance, as well as for operational planning and decision making purposes. Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows:



                Diluted earnings per common share                 FY 2020 Guidance
GAAP                                                              $16.04 to $16.54
Amortization of identifiable intangibles                                      0.49

Put/call valuation adjustments associated with the Company's non-consolidating minority interest investments

                               1.72
Adjusted (non-GAAP) - FY 2020 projected                           $18.25 to $18.75

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses